{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:17:55Z","timestamp":1791839875722,"version":"4.3.4"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jdcr.2022.07.015","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T22:40:41Z","timestamp":1658270441000},"page":"55-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Pityriasis rubra pilaris rapidly cleared with ixekizumab in an HIV-positive patient"],"prefix":"10.1016","volume":"27","author":[{"given":"Allison","family":"Kranyak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall","family":"Shuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jdcr.2022.07.015_bib1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s40257-017-0338-1","article-title":"A review on pityriasis rubra pilaris","volume":"19","author":"Wang","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"10.1016\/j.jdcr.2022.07.015_bib3","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-2133.1995.tb06939.x","article-title":"Pityriasis rubra pilaris and human immunodeficiency virus infection","volume":"133","author":"Miralles","year":"1995","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2022.07.015_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2230.1980.tb01676.x","article-title":"Pityriasis rubra pilaris","volume":"5","author":"Griffiths","year":"1980","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.jdcr.2022.07.015_bib4","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/jamadermatol.2020.0932","article-title":"Evaluation of ixekizumab treatment for patients with pityriasis rubra pilaris: a single-arm trial","volume":"156","author":"Haynes","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2022.07.015_bib5","first-page":"161","article-title":"HIV-associated complications: a systems-based approach","volume":"96","author":"Chu","year":"2017","journal-title":"Am Fam Physician"},{"issue":"4","key":"10.1016\/j.jdcr.2022.07.015_bib6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/jamadermatol.2016.5384","article-title":"Interleukin 23-Helper T cell 17 Axis as a treatment target for pityriasis rubra pilaris","volume":"153","author":"Feldmeyer","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2022.07.015_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/1203475419887731","article-title":"Use of biologics in pityriasis rubra pilaris refractory to first-line systemic therapy: a systematic review","volume":"24","author":"Naidoo","year":"2020","journal-title":"J Cutan Med Surg"},{"issue":"5","key":"10.1016\/j.jdcr.2022.07.015_bib8","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jaad.2021.04.041","article-title":"Drug survival of systemic and biologic monotherapy treatments for pityriasis rubra pilaris: a retrospective observational study","volume":"86","author":"Kettering","year":"2022","journal-title":"J Am Acad Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512622003204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512622003204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:24:54Z","timestamp":1762475094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512622003204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":8,"alternative-id":["S2352512622003204"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2022.07.015","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pityriasis rubra pilaris rapidly cleared with ixekizumab in an HIV-positive patient","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2022.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}